Kathryn Haskins
Concepts (386)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 74 | 2023 | 3254 | 5.070 |
Why?
| Autoantigens | 32 | 2022 | 396 | 4.820 |
Why?
| CD4-Positive T-Lymphocytes | 32 | 2022 | 959 | 4.740 |
Why?
| Mice, Inbred NOD | 66 | 2022 | 552 | 3.410 |
Why?
| Chromogranin A | 8 | 2021 | 39 | 3.190 |
Why?
| Islets of Langerhans | 41 | 2022 | 728 | 2.960 |
Why?
| T-Lymphocytes | 48 | 2020 | 1735 | 2.660 |
Why?
| Receptors, Antigen, T-Cell | 28 | 2021 | 615 | 2.180 |
Why?
| Insulin | 15 | 2023 | 2080 | 2.010 |
Why?
| Islet Amyloid Polypeptide | 5 | 2018 | 47 | 2.010 |
Why?
| Epitopes, T-Lymphocyte | 9 | 2021 | 170 | 1.900 |
Why?
| Peptides | 14 | 2023 | 848 | 1.830 |
Why?
| Diabetes Mellitus, Experimental | 15 | 2020 | 160 | 1.700 |
Why?
| Autoimmunity | 14 | 2022 | 812 | 1.580 |
Why?
| Insulin-Secreting Cells | 8 | 2023 | 317 | 1.500 |
Why?
| Peptide Fragments | 10 | 2022 | 665 | 1.430 |
Why?
| C-Peptide | 4 | 2021 | 138 | 1.370 |
Why?
| Mice | 90 | 2023 | 14841 | 1.340 |
Why?
| T-Lymphocytes, Regulatory | 5 | 2021 | 337 | 1.240 |
Why?
| Clone Cells | 29 | 2018 | 247 | 1.190 |
Why?
| Animals | 98 | 2023 | 31565 | 1.060 |
Why?
| Epitopes | 12 | 2022 | 434 | 0.970 |
Why?
| CD40 Antigens | 4 | 2012 | 81 | 0.910 |
Why?
| Islets of Langerhans Transplantation | 6 | 2022 | 52 | 0.870 |
Why?
| T-Lymphocytes, Helper-Inducer | 3 | 2019 | 127 | 0.840 |
Why?
| Antigen-Presenting Cells | 7 | 2014 | 150 | 0.820 |
Why?
| Adoptive Transfer | 16 | 2015 | 194 | 0.820 |
Why?
| Lymphocyte Activation | 16 | 2020 | 1036 | 0.800 |
Why?
| Mice, SCID | 15 | 2018 | 312 | 0.730 |
Why?
| Th1 Cells | 5 | 2009 | 123 | 0.710 |
Why?
| Nanoparticles | 3 | 2022 | 312 | 0.690 |
Why?
| Graft Survival | 1 | 2022 | 443 | 0.660 |
Why?
| CD4 Antigens | 5 | 2013 | 123 | 0.630 |
Why?
| Cells, Cultured | 13 | 2020 | 3861 | 0.620 |
Why?
| Mice, Transgenic | 20 | 2021 | 1947 | 0.590 |
Why?
| Pancreas | 6 | 2013 | 276 | 0.580 |
Why?
| Mice, Inbred BALB C | 17 | 2016 | 1144 | 0.570 |
Why?
| Recombinant Fusion Proteins | 3 | 2019 | 613 | 0.570 |
Why?
| Recombination, Genetic | 1 | 2018 | 176 | 0.570 |
Why?
| Macrophages | 6 | 2009 | 1259 | 0.560 |
Why?
| Histocompatibility Antigens Class II | 6 | 2013 | 350 | 0.530 |
Why?
| Immunotherapy | 1 | 2019 | 473 | 0.490 |
Why?
| Autoimmune Diseases | 7 | 2018 | 381 | 0.480 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 9 | 2012 | 309 | 0.470 |
Why?
| CD40 Ligand | 2 | 2012 | 37 | 0.470 |
Why?
| Immune Tolerance | 5 | 2021 | 321 | 0.450 |
Why?
| Prediabetic State | 3 | 2013 | 219 | 0.440 |
Why?
| CD8-Positive T-Lymphocytes | 7 | 2021 | 686 | 0.430 |
Why?
| Th2 Cells | 2 | 2007 | 154 | 0.430 |
Why?
| Histocompatibility Antigens | 3 | 2011 | 98 | 0.430 |
Why?
| Mice, Knockout | 8 | 2021 | 2562 | 0.420 |
Why?
| Spleen | 11 | 2013 | 485 | 0.410 |
Why?
| Antigen Presentation | 2 | 2021 | 188 | 0.400 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2007 | 1128 | 0.390 |
Why?
| Oxidative Stress | 4 | 2007 | 1068 | 0.380 |
Why?
| Histocompatibility Antigens Class I | 1 | 2012 | 170 | 0.360 |
Why?
| Flow Cytometry | 8 | 2015 | 1075 | 0.350 |
Why?
| Antigens, CD | 3 | 2008 | 440 | 0.350 |
Why?
| Macrophage Activation | 2 | 2007 | 163 | 0.340 |
Why?
| Specific Pathogen-Free Organisms | 3 | 2018 | 60 | 0.330 |
Why?
| Diabetes Mellitus | 5 | 2014 | 898 | 0.330 |
Why?
| Cytokines | 9 | 2009 | 1824 | 0.320 |
Why?
| Mass Spectrometry | 4 | 2023 | 622 | 0.310 |
Why?
| Amino Acid Sequence | 7 | 2016 | 1981 | 0.310 |
Why?
| Interferon-gamma | 8 | 2020 | 719 | 0.310 |
Why?
| Receptors, CCR8 | 1 | 2007 | 2 | 0.300 |
Why?
| Chemokine CCL1 | 1 | 2007 | 2 | 0.300 |
Why?
| Major Histocompatibility Complex | 10 | 2006 | 217 | 0.280 |
Why?
| HLA-DQ Antigens | 3 | 2021 | 174 | 0.280 |
Why?
| Transforming Growth Factor beta | 1 | 2009 | 445 | 0.270 |
Why?
| Cell Line | 13 | 2013 | 2629 | 0.250 |
Why?
| Disease Models, Animal | 3 | 2019 | 3498 | 0.240 |
Why?
| Humans | 35 | 2023 | 114043 | 0.230 |
Why?
| T-Lymphocyte Subsets | 4 | 2003 | 383 | 0.230 |
Why?
| Antibodies, Monoclonal | 12 | 2008 | 1257 | 0.230 |
Why?
| Thymus Gland | 5 | 2015 | 296 | 0.230 |
Why?
| Tyrosine | 2 | 2005 | 210 | 0.220 |
Why?
| Transglutaminases | 2 | 2013 | 142 | 0.200 |
Why?
| Female | 30 | 2022 | 59325 | 0.200 |
Why?
| Regeneration | 1 | 2004 | 158 | 0.200 |
Why?
| Cell Movement | 4 | 2014 | 863 | 0.200 |
Why?
| CD11c Antigen | 2 | 2019 | 38 | 0.190 |
Why?
| Metalloporphyrins | 1 | 2002 | 103 | 0.190 |
Why?
| B-Lymphocytes | 3 | 2015 | 762 | 0.180 |
Why?
| Polymorphism, Genetic | 1 | 2004 | 610 | 0.180 |
Why?
| Crosses, Genetic | 3 | 2018 | 136 | 0.180 |
Why?
| Molecular Sequence Data | 4 | 2016 | 2783 | 0.180 |
Why?
| Antigens, Surface | 2 | 2000 | 146 | 0.170 |
Why?
| Transgenes | 1 | 2001 | 170 | 0.170 |
Why?
| Endogenous Retroviruses | 1 | 2020 | 19 | 0.170 |
Why?
| Gene Products, gag | 1 | 2020 | 36 | 0.170 |
Why?
| Cell Proliferation | 3 | 2019 | 2173 | 0.170 |
Why?
| Antigens, Differentiation | 1 | 2000 | 79 | 0.170 |
Why?
| HLA-DRB1 Chains | 1 | 2020 | 97 | 0.170 |
Why?
| Insulinoma | 2 | 2002 | 29 | 0.160 |
Why?
| Mice, Inbred Strains | 9 | 1998 | 398 | 0.160 |
Why?
| Recurrence | 1 | 2022 | 925 | 0.160 |
Why?
| Immunoconjugates | 1 | 2000 | 87 | 0.160 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2012 | 2087 | 0.160 |
Why?
| Celiac Disease | 1 | 2021 | 264 | 0.150 |
Why?
| Cytoplasmic Granules | 3 | 2000 | 81 | 0.150 |
Why?
| Animals, Genetically Modified | 1 | 2019 | 215 | 0.150 |
Why?
| Mice, Inbred C57BL | 6 | 2015 | 4680 | 0.150 |
Why?
| Lymphoid Tissue | 1 | 2018 | 62 | 0.150 |
Why?
| Forkhead Transcription Factors | 1 | 2019 | 170 | 0.150 |
Why?
| Exocytosis | 1 | 2018 | 89 | 0.150 |
Why?
| Immune System | 1 | 2019 | 171 | 0.150 |
Why?
| Cell Differentiation | 4 | 2020 | 1695 | 0.150 |
Why?
| Chromatography, Gel | 2 | 2012 | 122 | 0.140 |
Why?
| Leukocytes | 1 | 1998 | 272 | 0.140 |
Why?
| HLA-A2 Antigen | 1 | 2016 | 35 | 0.140 |
Why?
| Cytotoxicity, Immunologic | 3 | 2002 | 188 | 0.130 |
Why?
| Diabetic Angiopathies | 2 | 2011 | 246 | 0.130 |
Why?
| Disease Progression | 3 | 2019 | 2371 | 0.130 |
Why?
| Cell Division | 3 | 2004 | 754 | 0.130 |
Why?
| Hybridomas | 11 | 2009 | 230 | 0.120 |
Why?
| Biocompatible Materials | 2 | 2012 | 372 | 0.120 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 787 | 0.120 |
Why?
| Microsatellite Repeats | 1 | 2015 | 137 | 0.120 |
Why?
| Antigens, Neoplasm | 2 | 1994 | 222 | 0.120 |
Why?
| Male | 19 | 2021 | 55396 | 0.120 |
Why?
| Serine Endopeptidases | 1 | 2015 | 101 | 0.120 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 2 | 2007 | 84 | 0.120 |
Why?
| CTLA-4 Antigen | 2 | 2008 | 76 | 0.120 |
Why?
| Signal Transduction | 5 | 2012 | 4501 | 0.110 |
Why?
| Glutamate Decarboxylase | 3 | 2008 | 160 | 0.110 |
Why?
| Nitric Oxide | 3 | 2007 | 817 | 0.110 |
Why?
| Dendritic Cells | 2 | 2012 | 435 | 0.110 |
Why?
| Histocompatibility Testing | 1 | 2013 | 115 | 0.110 |
Why?
| Microscopy, Fluorescence | 2 | 2012 | 393 | 0.110 |
Why?
| Primary Cell Culture | 1 | 2013 | 148 | 0.110 |
Why?
| Proteomics | 2 | 2022 | 815 | 0.110 |
Why?
| Citrulline | 1 | 2013 | 39 | 0.100 |
Why?
| Fibrinogen | 1 | 2013 | 143 | 0.100 |
Why?
| Amino Acid Motifs | 2 | 2010 | 197 | 0.100 |
Why?
| Interleukin-2 | 4 | 2000 | 413 | 0.100 |
Why?
| Lymph Nodes | 2 | 2013 | 415 | 0.100 |
Why?
| Transduction, Genetic | 1 | 2012 | 113 | 0.100 |
Why?
| Arthritis, Experimental | 1 | 2013 | 130 | 0.090 |
Why?
| Transforming Growth Factor beta1 | 2 | 2012 | 153 | 0.090 |
Why?
| Lymphocyte Transfusion | 3 | 2005 | 19 | 0.090 |
Why?
| Complementarity Determining Regions | 2 | 2012 | 43 | 0.090 |
Why?
| Immunodominant Epitopes | 2 | 2009 | 25 | 0.090 |
Why?
| Carotid Artery Diseases | 1 | 2011 | 57 | 0.090 |
Why?
| RNA, Messenger | 4 | 2005 | 2550 | 0.090 |
Why?
| Autoantibodies | 3 | 2013 | 1347 | 0.090 |
Why?
| Endothelium, Vascular | 2 | 2007 | 830 | 0.090 |
Why?
| Ovalbumin | 3 | 2021 | 161 | 0.090 |
Why?
| HLA-A Antigens | 1 | 2010 | 49 | 0.090 |
Why?
| Up-Regulation | 2 | 2013 | 802 | 0.080 |
Why?
| Receptors, Interleukin-2 | 2 | 2000 | 64 | 0.080 |
Why?
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 3 | 2006 | 25 | 0.080 |
Why?
| Chromosome Mapping | 2 | 2004 | 486 | 0.080 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 52 | 0.080 |
Why?
| CD28 Antigens | 1 | 2008 | 47 | 0.080 |
Why?
| Gene Expression | 1 | 2013 | 1417 | 0.080 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2008 | 58 | 0.080 |
Why?
| Disease Susceptibility | 2 | 2004 | 316 | 0.080 |
Why?
| Polyethylene Glycols | 3 | 2012 | 561 | 0.080 |
Why?
| Biomarkers | 1 | 2018 | 3397 | 0.080 |
Why?
| Inducible T-Cell Co-Stimulator Protein | 1 | 2007 | 9 | 0.070 |
Why?
| Organ Specificity | 1 | 2008 | 266 | 0.070 |
Why?
| CD11b Antigen | 1 | 2007 | 56 | 0.070 |
Why?
| Macrophages, Peritoneal | 1 | 2007 | 93 | 0.070 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2007 | 140 | 0.070 |
Why?
| Pancreatic Neoplasms | 1 | 1994 | 721 | 0.070 |
Why?
| Hydrogels | 3 | 2012 | 573 | 0.070 |
Why?
| Chemotaxis | 1 | 2007 | 128 | 0.070 |
Why?
| Child | 5 | 2019 | 18400 | 0.070 |
Why?
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2004 | 21 | 0.060 |
Why?
| Mice, Mutant Strains | 3 | 1991 | 271 | 0.060 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 924 | 0.060 |
Why?
| Prostaglandins | 1 | 2005 | 77 | 0.060 |
Why?
| Isoenzymes | 1 | 2006 | 283 | 0.060 |
Why?
| Genes, T-Cell Receptor | 1 | 2005 | 6 | 0.060 |
Why?
| Receptors, Chemokine | 1 | 2005 | 44 | 0.060 |
Why?
| Receptors, Cytokine | 1 | 2005 | 33 | 0.060 |
Why?
| Species Specificity | 4 | 2006 | 541 | 0.060 |
Why?
| Cell Adhesion Molecules | 1 | 2005 | 167 | 0.060 |
Why?
| Immunoglobulin Allotypes | 1 | 1984 | 6 | 0.060 |
Why?
| Lymphocyte Depletion | 3 | 2000 | 115 | 0.060 |
Why?
| Arthritis, Rheumatoid | 1 | 2013 | 1002 | 0.060 |
Why?
| Rats | 5 | 2000 | 4913 | 0.060 |
Why?
| Aging | 4 | 2005 | 1611 | 0.060 |
Why?
| Mice, Congenic | 1 | 2004 | 21 | 0.060 |
Why?
| Molecular Mimicry | 1 | 2003 | 35 | 0.060 |
Why?
| Chemokines | 1 | 2005 | 215 | 0.050 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 2000 | 315 | 0.050 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 742 | 0.050 |
Why?
| Extracellular Matrix | 1 | 2007 | 436 | 0.050 |
Why?
| Aspartic Acid | 1 | 2023 | 77 | 0.050 |
Why?
| Genes, RAG-1 | 1 | 2003 | 11 | 0.050 |
Why?
| Immunoglobulin G | 2 | 1997 | 766 | 0.050 |
Why?
| Adolescent | 3 | 2019 | 17800 | 0.050 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 126 | 0.050 |
Why?
| Cathepsin D | 1 | 2022 | 14 | 0.050 |
Why?
| DNA Primers | 1 | 2004 | 508 | 0.050 |
Why?
| Insulin, Regular, Human | 1 | 2022 | 33 | 0.050 |
Why?
| Vasodilation | 1 | 2005 | 418 | 0.050 |
Why?
| Solubility | 2 | 2000 | 223 | 0.050 |
Why?
| Glucose | 3 | 2007 | 899 | 0.050 |
Why?
| Antibody Specificity | 5 | 1996 | 175 | 0.050 |
Why?
| Respiratory Burst | 1 | 2002 | 16 | 0.050 |
Why?
| Molecular Weight | 5 | 2006 | 328 | 0.050 |
Why?
| RNA, Small Interfering | 1 | 2004 | 534 | 0.050 |
Why?
| Superoxide Dismutase | 1 | 2003 | 305 | 0.050 |
Why?
| Adult | 4 | 2019 | 30375 | 0.050 |
Why?
| In Vitro Techniques | 1 | 2023 | 1003 | 0.050 |
Why?
| Cytoprotection | 1 | 2021 | 51 | 0.050 |
Why?
| K562 Cells | 1 | 2021 | 73 | 0.050 |
Why?
| Leukemia L1210 | 1 | 2001 | 7 | 0.050 |
Why?
| Phosphotyrosine | 1 | 2001 | 33 | 0.050 |
Why?
| Interphase | 1 | 2001 | 32 | 0.050 |
Why?
| L-Selectin | 1 | 2001 | 25 | 0.050 |
Why?
| Perforin | 1 | 2001 | 18 | 0.050 |
Why?
| Gene Rearrangement | 1 | 2002 | 135 | 0.050 |
Why?
| Pore Forming Cytotoxic Proteins | 1 | 2001 | 15 | 0.050 |
Why?
| Antigens, Viral | 1 | 2021 | 176 | 0.050 |
Why?
| Alleles | 1 | 2003 | 789 | 0.040 |
Why?
| T-Cell Antigen Receptor Specificity | 2 | 2012 | 41 | 0.040 |
Why?
| Injections, Intravenous | 1 | 2001 | 198 | 0.040 |
Why?
| fas Receptor | 1 | 2001 | 91 | 0.040 |
Why?
| Integrins | 1 | 2001 | 79 | 0.040 |
Why?
| Chromatography, Ion Exchange | 1 | 2000 | 48 | 0.040 |
Why?
| Detergents | 1 | 2000 | 41 | 0.040 |
Why?
| Hemocyanins | 1 | 2000 | 55 | 0.040 |
Why?
| Abatacept | 1 | 2000 | 40 | 0.040 |
Why?
| Antigens | 1 | 2021 | 317 | 0.040 |
Why?
| Immunophenotyping | 1 | 2001 | 274 | 0.040 |
Why?
| Cross Reactions | 1 | 2020 | 118 | 0.040 |
Why?
| Cell Lineage | 1 | 2021 | 308 | 0.040 |
Why?
| Glycoproteins | 1 | 2021 | 304 | 0.040 |
Why?
| Mice, Inbred DBA | 3 | 2013 | 174 | 0.040 |
Why?
| Maternal-Fetal Exchange | 2 | 1997 | 151 | 0.040 |
Why?
| Promoter Regions, Genetic | 1 | 2004 | 1131 | 0.040 |
Why?
| Viral Proteins | 1 | 2021 | 281 | 0.040 |
Why?
| Gene Expression Regulation | 2 | 2012 | 2321 | 0.040 |
Why?
| Cell-Derived Microparticles | 1 | 2020 | 56 | 0.040 |
Why?
| Clonal Anergy | 1 | 1999 | 53 | 0.040 |
Why?
| Macromolecular Substances | 3 | 1991 | 200 | 0.040 |
Why?
| Pancreatitis | 1 | 2000 | 105 | 0.040 |
Why?
| Interleukin-13 | 1 | 1999 | 121 | 0.040 |
Why?
| Transfection | 1 | 2001 | 863 | 0.040 |
Why?
| Membrane Glycoproteins | 1 | 2001 | 429 | 0.040 |
Why?
| Lipopolysaccharides | 1 | 2002 | 813 | 0.040 |
Why?
| Intracellular Membranes | 1 | 1998 | 73 | 0.040 |
Why?
| Obesity | 1 | 1990 | 2505 | 0.040 |
Why?
| Muramidase | 1 | 1998 | 72 | 0.040 |
Why?
| NF-kappa B | 1 | 2002 | 636 | 0.040 |
Why?
| Immunity, Maternally-Acquired | 1 | 1997 | 18 | 0.040 |
Why?
| Antibodies | 1 | 2000 | 365 | 0.040 |
Why?
| Rats, Inbred Strains | 2 | 1990 | 360 | 0.040 |
Why?
| Materials Testing | 2 | 2012 | 337 | 0.040 |
Why?
| Multigene Family | 1 | 1997 | 190 | 0.030 |
Why?
| Animals, Newborn | 3 | 2005 | 777 | 0.030 |
Why?
| Glutathione | 1 | 1998 | 293 | 0.030 |
Why?
| Tumor Cells, Cultured | 2 | 2000 | 845 | 0.030 |
Why?
| Phosphorylation | 1 | 2001 | 1558 | 0.030 |
Why?
| Cloning, Molecular | 3 | 2003 | 522 | 0.030 |
Why?
| Cell Membrane | 1 | 2000 | 670 | 0.030 |
Why?
| Leukocytes, Mononuclear | 1 | 2019 | 489 | 0.030 |
Why?
| NADPH Oxidases | 2 | 2007 | 105 | 0.030 |
Why?
| DNA-Binding Proteins | 1 | 2003 | 1311 | 0.030 |
Why?
| Insulin Antibodies | 1 | 1996 | 102 | 0.030 |
Why?
| Heat-Shock Proteins | 1 | 1996 | 112 | 0.030 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 1996 | 154 | 0.030 |
Why?
| Immunohistochemistry | 2 | 2000 | 1624 | 0.030 |
Why?
| Thymocytes | 1 | 2015 | 28 | 0.030 |
Why?
| Immunization | 2 | 1996 | 397 | 0.030 |
Why?
| Stromal Cells | 1 | 2015 | 96 | 0.030 |
Why?
| Mice, Inbred AKR | 4 | 1997 | 34 | 0.030 |
Why?
| Membrane Proteins | 1 | 2000 | 1016 | 0.030 |
Why?
| Genetic Linkage | 1 | 1995 | 294 | 0.030 |
Why?
| Centrifugation, Density Gradient | 1 | 1994 | 40 | 0.030 |
Why?
| Culture Techniques | 1 | 1994 | 78 | 0.030 |
Why?
| Cell Fractionation | 1 | 1994 | 51 | 0.030 |
Why?
| Binding Sites, Antibody | 2 | 1984 | 36 | 0.030 |
Why?
| Journal Impact Factor | 1 | 2014 | 27 | 0.030 |
Why?
| Antigen-Antibody Reactions | 2 | 1984 | 49 | 0.030 |
Why?
| Genetic Markers | 1 | 1995 | 320 | 0.030 |
Why?
| Gene Rearrangement, T-Lymphocyte | 1 | 1993 | 13 | 0.030 |
Why?
| Rats, Inbred BB | 1 | 1993 | 5 | 0.030 |
Why?
| Immunosuppressive Agents | 2 | 2012 | 641 | 0.030 |
Why?
| Cell Survival | 2 | 2007 | 1014 | 0.030 |
Why?
| Young Adult | 2 | 2019 | 10444 | 0.030 |
Why?
| Immunity, Innate | 1 | 1998 | 720 | 0.030 |
Why?
| Collagen Type II | 1 | 2013 | 48 | 0.030 |
Why?
| CD8 Antigens | 1 | 1992 | 69 | 0.030 |
Why?
| Trinitrobenzenes | 1 | 1992 | 13 | 0.030 |
Why?
| Adenoma, Islet Cell | 1 | 1992 | 10 | 0.030 |
Why?
| Haptens | 1 | 1992 | 21 | 0.030 |
Why?
| Hybrid Cells | 1 | 1992 | 49 | 0.030 |
Why?
| Publishing | 1 | 2014 | 123 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 1993 | 990 | 0.020 |
Why?
| Kinetics | 1 | 1995 | 1547 | 0.020 |
Why?
| Immunoglobulin Idiotypes | 4 | 1983 | 19 | 0.020 |
Why?
| Receptors, Antigen, B-Cell | 1 | 1992 | 107 | 0.020 |
Why?
| Periodicals as Topic | 1 | 2014 | 180 | 0.020 |
Why?
| Coculture Techniques | 1 | 2012 | 198 | 0.020 |
Why?
| Mice, Nude | 1 | 1993 | 628 | 0.020 |
Why?
| Base Sequence | 2 | 1993 | 2114 | 0.020 |
Why?
| Neointima | 1 | 2011 | 13 | 0.020 |
Why?
| Germ-Line Mutation | 1 | 2012 | 131 | 0.020 |
Why?
| Mice, Inbred CBA | 1 | 1990 | 49 | 0.020 |
Why?
| Collagen | 1 | 2013 | 414 | 0.020 |
Why?
| CD4 Lymphocyte Count | 1 | 2011 | 256 | 0.020 |
Why?
| Sex Factors | 1 | 1995 | 1706 | 0.020 |
Why?
| Interleukin-10 | 1 | 2012 | 293 | 0.020 |
Why?
| Age Factors | 2 | 1995 | 2885 | 0.020 |
Why?
| Genes, MHC Class II | 1 | 1989 | 69 | 0.020 |
Why?
| Leukemia, Lymphoid | 2 | 2006 | 27 | 0.020 |
Why?
| Epitope Mapping | 1 | 2009 | 51 | 0.020 |
Why?
| Pituitary Gland | 1 | 1989 | 147 | 0.020 |
Why?
| Trypsin | 2 | 2006 | 66 | 0.020 |
Why?
| Lymphokines | 1 | 1988 | 110 | 0.020 |
Why?
| Conserved Sequence | 1 | 2009 | 218 | 0.020 |
Why?
| Tissue Distribution | 2 | 1985 | 285 | 0.020 |
Why?
| Cell Separation | 1 | 1988 | 290 | 0.020 |
Why?
| Stem Cell Transplantation | 1 | 2008 | 148 | 0.020 |
Why?
| Kidney Transplantation | 1 | 1992 | 538 | 0.020 |
Why?
| Salivary Glands | 1 | 2006 | 31 | 0.020 |
Why?
| Mucoproteins | 1 | 2005 | 10 | 0.020 |
Why?
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2005 | 3 | 0.020 |
Why?
| Acetophenones | 1 | 2005 | 14 | 0.020 |
Why?
| Onium Compounds | 1 | 2005 | 10 | 0.020 |
Why?
| Hydrogen Peroxide | 1 | 2007 | 288 | 0.020 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 58 | 0.020 |
Why?
| Cell Adhesion | 1 | 2007 | 426 | 0.020 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2005 | 72 | 0.020 |
Why?
| Drug Compounding | 1 | 2005 | 89 | 0.020 |
Why?
| Acetylcholine | 1 | 2005 | 166 | 0.020 |
Why?
| History, 20th Century | 1 | 2006 | 265 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 1993 | 2090 | 0.010 |
Why?
| Precipitin Tests | 1 | 1984 | 88 | 0.010 |
Why?
| Isoelectric Point | 1 | 1984 | 22 | 0.010 |
Why?
| Protein Binding | 1 | 2009 | 1888 | 0.010 |
Why?
| Disulfides | 1 | 1984 | 90 | 0.010 |
Why?
| Genes, T-Cell Receptor alpha | 1 | 2003 | 11 | 0.010 |
Why?
| Genes, T-Cell Receptor beta | 1 | 2003 | 18 | 0.010 |
Why?
| Chemical Precipitation | 1 | 1983 | 37 | 0.010 |
Why?
| Aorta | 1 | 2005 | 388 | 0.010 |
Why?
| Inflammation | 2 | 2006 | 2464 | 0.010 |
Why?
| DNA, Complementary | 1 | 2003 | 255 | 0.010 |
Why?
| Receptors, Immunologic | 1 | 1983 | 198 | 0.010 |
Why?
| Oxidation-Reduction | 1 | 2005 | 917 | 0.010 |
Why?
| Homeostasis | 1 | 2005 | 570 | 0.010 |
Why?
| Haplotypes | 1 | 2003 | 448 | 0.010 |
Why?
| Time Factors | 1 | 2012 | 6077 | 0.010 |
Why?
| Blood Glucose | 3 | 1999 | 1827 | 0.010 |
Why?
| Growth Inhibitors | 1 | 2000 | 43 | 0.010 |
Why?
| Injections, Intraperitoneal | 1 | 2000 | 99 | 0.010 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2000 | 157 | 0.010 |
Why?
| Pancreatic Ducts | 1 | 2000 | 69 | 0.010 |
Why?
| Nitric Oxide Synthase | 1 | 2000 | 209 | 0.010 |
Why?
| Complement C5 | 1 | 1999 | 73 | 0.010 |
Why?
| Cell Transplantation | 1 | 1999 | 35 | 0.010 |
Why?
| Epithelium | 1 | 2000 | 295 | 0.010 |
Why?
| Rats, Wistar | 1 | 2000 | 368 | 0.010 |
Why?
| H-2 Antigens | 1 | 1999 | 110 | 0.010 |
Why?
| Models, Immunological | 1 | 1999 | 90 | 0.010 |
Why?
| Interleukin-4 | 1 | 1999 | 204 | 0.010 |
Why?
| Conalbumin | 1 | 1997 | 3 | 0.010 |
Why?
| Apoptosis | 1 | 2007 | 2349 | 0.010 |
Why?
| Immune Sera | 1 | 1997 | 79 | 0.010 |
Why?
| Immunoglobulin E | 1 | 1999 | 314 | 0.010 |
Why?
| Superantigens | 1 | 1997 | 69 | 0.010 |
Why?
| Enterotoxins | 1 | 1997 | 88 | 0.010 |
Why?
| Injections, Subcutaneous | 1 | 1997 | 134 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 2000 | 743 | 0.010 |
Why?
| Genes, Immunoglobulin | 1 | 1996 | 26 | 0.010 |
Why?
| Spodoptera | 1 | 1996 | 36 | 0.010 |
Why?
| Baculoviridae | 1 | 1996 | 44 | 0.010 |
Why?
| Homeodomain Proteins | 1 | 1999 | 463 | 0.010 |
Why?
| Pregnancy | 2 | 1997 | 5499 | 0.010 |
Why?
| Antibody Formation | 1 | 1996 | 266 | 0.010 |
Why?
| Staphylococcus aureus | 1 | 1997 | 385 | 0.010 |
Why?
| Submandibular Gland | 1 | 1993 | 15 | 0.010 |
Why?
| Oligodeoxyribonucleotides | 1 | 1993 | 138 | 0.010 |
Why?
| Globins | 1 | 1989 | 21 | 0.010 |
Why?
| Antigens, Ly | 1 | 1984 | 45 | 0.000 |
Why?
| Isoelectric Focusing | 1 | 1983 | 33 | 0.000 |
Why?
| Chickens | 1 | 1983 | 180 | 0.000 |
Why?
| Birds | 1 | 1983 | 71 | 0.000 |
Why?
| Immunologic Techniques | 1 | 1983 | 39 | 0.000 |
Why?
| DNA | 1 | 1989 | 1350 | 0.000 |
Why?
| Molecular Conformation | 1 | 1983 | 135 | 0.000 |
Why?
|
|
Haskins's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|